Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Obesity Management Market: Phentermine and Topiramate Expected to be the Second Most Lucrative Segment by Drug Type: Global Industry Analysis and Opportunity Assessment 2017-2027

Table of Content

Table Of Content
1. Executive Summary

2. Market Introduction
2.1.Market Definition
2.2.Market Taxonomy

3. Global Obesity Management Market Analysis Scenario
3.1.Market Size(US$ Mn) and Forecast
3.1 .1.Market Size and Y - o - Y Growth
3.1 .2.Absolute $ Opportunity
3.2.Market Overview

4. Market Dynamics
4.1.Macro - economic Factors
4.2.Drivers
4.2 .1.Supply and Demand Side
4.3.Restraints
4.4.Opportunity
4.5.Forecast Factors– Relevance and Impact
4.6.Scenario Forecast
4.7.Trends
4.8.Regulations Scenario
4.9.Drug Pipeline Assessment
4.10.Epidemiology Analysis

5. Global Obesity Management Market Analysis and Forecasts, By Drug Type
5.1.Introduction
5.2.Basis Point Share(BPS) Analysis By Drug Type
5.3.Y - o - Y Growth Projections By Drug Type
5.4.Market Value Forecast By Drug Type, 2017– 2027
5.4 .1.Bupropion and Naltrexone
5.4 .2.Orlistat
5.4 .3.Lorcaserin
5.4 .4.Phentermine and Topiramate
5.4 .5.Liraglutide
5.5.Market Attractiveness By Drug Type

6. Global Obesity Management Market Analysis and Forecasts, By Surgery Type
6.1.Introduction
6.2.Basis Point Share(BPS) Analysis By Surgery Type
6.3.Y - o - Y Growth Projections By Surgery Type
6.4.Market Value Forecast By Surgery Type, 2017– 2027
6.4 .1.Gastric Bypass Surgery
6.4 .2.Adjustable Gastric Banding Surgery
6.4 .3.Gastric Sleeve Surgery
6.4 .4.Duodenal Switch Surgery
6.4 .5.Others
6.5.Market Attractiveness By Surgery Type

7. Global Obesity Management Market Analysis and Forecasts, By Distribution Channel
7.1.Introduction
7.2.Basis Point Share(BPS) Analysis By Distribution Channel
7.3.Y - o - Y Growth Projections By Distribution Channel
7.4.Market Value Forecast By Distribution Channel, 2017– 2027
7.4 .1.Hospitals Pharmacies
7.4 .2.Retail Pharmacies
7.4 .3.E - Commerce
7.5.Market Attractiveness By Distribution Channel

8. Global Obesity Management Market Analysis and Forecasts, By Region
8.1.Basis Point Share(BPS) Analysis By Region
8.2.Y - o - Y Growth Projections By Region
8.3.Market Value Forecast By Region
8.3 .1.North America
8.3 .2.Latin America
8.3 .3.Western Europe
8.3 .4.Eastern Europe
8.3 .5.APEJ
8.3 .6.Japan
8.3 .7.MEA
8.4.Market Attractiveness By Region

9. North America Global Obesity Management Market Analysis and Forecast
9.1.Introduction
9.1 .1.Basis Point Share(BPS) Analysis By Drug Type
9.1 .2.Y - o - Y Growth Projections By Drug Type
9.2.Market Value Forecast By Drug Type, 2017– 2027
9.2 .1.Bupropion and Naltrexone
9.2 .2.Orlistat
9.2 .3.Lorcaserin
9.2 .4.Phentermine and Topiramate
9.2 .5.Liraglutide
9.3.Market Value Forecast By Surgery Type, 2017– 2027
9.3 .1.Gastric Bypass Surgery
9.3 .2.Adjustable Gastric Banding Surgery
9.3 .3.Gastric Sleeve Surgery
9.3 .4.Duodenal Switch Surgery
9.3 .5.Others
9.4.Market Value Forecast By Distribution Channel, 2017– 2027
9.4 .1.Hospitals Pharmacies
9.4 .2.Retail Pharmacies
9.4 .3.E - Commerce
9.5.Market Value Forecast By Country, 2017– 2027
9.5 .1.U.S.
9.5 .2.Canada
9.6.Market Attractiveness Analysis
9.6 .1.By Drug Type
9.6 .2.By Surgery Type
9.6 .3.By Distribution Channel
9.6 .4.By Country

10. Latin America Global Obesity Management Market Analysis and Forecast
10.1.Introduction
10.1 .1.Basis Point Share(BPS) Analysis By Drug Type
10.1 .2.Y - o - Y Growth Projections By Drug Type
10.2.Market Value Forecast By Drug Type, 2017– 2027
10.2 .1.Bupropion and Naltrexone
10.2 .2.Orlistat
10.2 .3.Lorcaserin
10.2 .4.Phentermine and Topiramate
10.2 .5.Liraglutide "

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote